Stand out for this role — generate a tailored resume and cover letter in about a minute.
Gilder Search Group is seeking a Field Sales Cell Therapy Specialist in Nashville, TN, covering Tennessee and Alabama. You will own strategic accounts, build deep relationships with hematologists and oncologists, and lead the adoption of a BCMA-directed CAR-T therapy.
This high-visibility role requires scientific acumen, independence, and a track record of selling complex therapies. Compensation includes a base in the $180K–$190K range plus up to $100K annual bonus, equity, and a car allowance.
Location: Nashville, TN | Field-Based
Territory: Tennessee / Alabama Metro Corridor
Compensation: $180K–$190K base + up to $100K annual bonus + equity + car allowance
Reports to: Regional Sales Director
Type: Full-time | Field Sales | High-Visibility Commercial Role
Sector: Biotech | Hematology/Oncology | Cell Therapy
The company is a commercial-stage biotechnology organization advancing a market-leading CAR-T cell therapy for patients with relapsed or refractory multiple myeloma. The therapy is commercialized in partnership with a major global pharmaceutical company and is supported by a focused national field organization of approximately 43 representatives and six Regional Sales Directors.
This is a small, high-visibility commercial team where individual performance, account ownership, scientific credibility, and persistence matter. New hires receive an eight-week formal training curriculum, followed by an installation phase and field-based development.
We’re hiring a Cell Therapy Specialist to own a strategically important Nashville-based territory covering key oncology, transplant, and cell therapy centers across Tennessee and Alabama.
This is not a traditional transactional pharmaceutical sales role. Success requires the ability to master complex science, develop deep relationships across multidisciplinary care teams, understand the competitive myeloma landscape, and navigate the operational complexity of cell therapy.
You’ll work with hematologists, oncologists, transplant coordinators, cell therapy program leaders, and other stakeholders at institutions including major academic cancer centers and community oncology networks throughout the region.
The strongest candidates will combine drive, resilience, intellectual curiosity, and account ownership. Prior cell therapy or hematology/oncology experience is valuable, but the organization is willing to invest significant training and ramp time in exceptional candidates with strong learning agility and a track record of succeeding in demanding environments.
We are particularly interested in candidates with backgrounds in: